Last reviewed · How we verify

Hypertension — Treatment Landscape & Competitive Intelligence

Hypertension (Cardiovascular) competitive landscape: 7 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

Cardiovascular 7 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Hypertension, deduplicated by molecule. See the full disease page for line-of-therapy detail.

DrugGenericSponsorClassTargetLine of therapyFirst approval
Tryvio APROCITENTAN Idorsia Endothelin Receptor Antagonist [EPC] 2025-01-01
Candesartan Cilexetil CILEXETIL Alembic Ace Inhibitor 2021-01-01
olmesartan medoxomil-hydrochlorothiazide OLMESARTAN Cosette Thiazide Diuretic [EPC] 2019-01-01
Prazosin Hcl prazosin-hcl Pfizer prazosin 5-hydroxytryptamine receptor 1D 1976-01-01
Caduet Amlodipine Besylate Pfizer Inc. Dihydropyridine calcium channel blocker L-type calcium channel
Lisinopril/HCTZ HCTZ Direct_Rx Thiazide Diuretic [EPC]
Minnebro esaxerenone Daiichi Sankyo Mineralocorticoid receptor

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

  1. · 2 drugs in Hypertension
  2. Alembic · 1 drug in Hypertension
  3. Cosette · 1 drug in Hypertension
  4. Daiichi Sankyo · 1 drug in Hypertension
  5. Direct_Rx · 1 drug in Hypertension
  6. Idorsia · 1 drug in Hypertension
  7. Pfizer · 1 drug in Hypertension
  8. Pfizer Inc. · 1 drug in Hypertension

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Hypertension:

Cite this brief

Drug Landscape (2026). Hypertension — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/hypertension. Accessed 2026-05-13.

Related